Last reviewed · How we verify
recombinant human erythropoietin, rhEpo
recombinant human erythropoietin, rhEpo is a Small molecule drug developed by Claudia Sue Robertson. It is currently in Phase 2 development.
At a glance
| Generic name | recombinant human erythropoietin, rhEpo |
|---|---|
| Sponsor | Claudia Sue Robertson |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study of SSS06 for Chemotherapy-Induced Anemia in Non-Myeloid Malignancies (PHASE2)
- Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ) (PHASE3)
- Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe) (PHASE2)
- Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) (PHASE3)
- Recombinant Human Erythropoietin Improve Neurodevelopmental Outcomes in Extremely Preterm Infants (NA)
- Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD) (PHASE3)
- Safety Study of Erythropoietin (EPO) in Parkinson's Disease (PHASE1)
- Randomized, Double-blind, Safety and Efficacy of Recombinant Human Erythropoietin in Amyotrophic Lateral Sclerosis (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- recombinant human erythropoietin, rhEpo CI brief — competitive landscape report
- recombinant human erythropoietin, rhEpo updates RSS · CI watch RSS
- Claudia Sue Robertson portfolio CI
Frequently asked questions about recombinant human erythropoietin, rhEpo
What is recombinant human erythropoietin, rhEpo?
recombinant human erythropoietin, rhEpo is a Small molecule drug developed by Claudia Sue Robertson.
Who makes recombinant human erythropoietin, rhEpo?
recombinant human erythropoietin, rhEpo is developed by Claudia Sue Robertson (see full Claudia Sue Robertson pipeline at /company/claudia-sue-robertson).
What development phase is recombinant human erythropoietin, rhEpo in?
recombinant human erythropoietin, rhEpo is in Phase 2.